Building a Global RWD Strategy: From Fragmented Data to Decision-Grade Evidence
9:30 am - Wednesday 28th October 2026
In this fireside chat, industry leaders will examine these questions from different
perspectives:
- What does a biopharma team need to consider when selecting data to support a global evidence strategy?
- How can federated access and harmonization enable research across markets and datasets with different structures and standards?
- How should researchers assess whether those data are fit for a particular strategic, regulatory or market-access decision?
